FDA Adverse Event Injury Summary report: N

G7 PPS LTD ACETABULAR SHELL

MDR report key: 7957667 · Received October 11, 2018

Report

Report Number
0001825034-2018-09663
Event Type
Injury
Date Received
October 11, 2018
Date of Event
July 8, 2013
Report Date
October 11, 2018
Manufacturer
ZIMMER BIOMET, INC.
Product Code
PBI
PMA / PMN Number
PK121874
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: G7 NEUTRAL LINER, # ITEM 010000857, LOT 2921390; CER BIOLOXD OPTION HEAD, # ITEM 650-1057, LOT 773770; CER OPTION TYPE 1 TAPER SLEVE, # ITEM 650-1065, LOT 683160; TPRLC133 MP T1 PPS SO 6X97.5MM, # ITEM 51-108060, LOT 2479105. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034-2018-06147, 0001825034-2018-06149, 0001825034-2018-06153 AND 0001825034-2018-06154. REPORTED EVENT WAS CONFIRMED BY REVIEW OF OPERATIVE NOTES PROVIDED. REVISION OP NOTE SHOWS ESTIMATED BLOOD LOSS 1700ML. THE PATIENT WAS REVISED DUE TO INCREASED PAIN, LEG LENGTH INEQUALITY, CHRONIC PERIPROSTHETIC FRACTURE WITH A GROSSLY LOOSE STEM. CERCLAGE CABLES PLACED TO REDUCE THE LESSER TROCHANTERIC CHRONIC FRACTURE. CUP AND LINER LEFT INTACT. FEMORAL HEAD/NECK AND STEM REPLACED. DEVICE HISTORY RECORD WAS REVIEWED AND NO DISCREPANCIES RELEVANT TO THE REPORTED EVENT WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE ESTIMATED BLOOD LOSS WAS 1700 ML DURING REVISION DUE TO PERIPROSTHETIC FEMORAL FRACTURE. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
798724 G7 PPS LTD ACETABULAR SHELL PROSTHESIS HIP PBI ZIMMER BIOMET, INC. N/A 2804310

Patients

Seq Age Sex Outcome Treatment
1 62 YR